This year, we are excited to introduce our first ever Stability Studies conference. Join us at the Killashee Hotel, Naas on Thursday 13th October 2022 to hear experts from the pharmaceutical industry share their tips on evaluating and managing stability studies.
Why join us at our 2022 Stability Studies Conference?
The best business case for attending this conference is the wealth of information shared by our speakers on risk-based stability studies, lean product development and stability storage along with plenty of networking opportunities.
With pharmaceutical and medical device companies under increased pressure to meet regulatory requirements while decreasing margins and avoiding product recalls the impact of stability studies on product development and commercialisation has never been greater.
Listen to a morning of analytical and quality professionals discuss their experiences around managing and evaluating stability studies.
Who is speaking at the Stability Studies Conference?
We have a full line-up of pharmaceutical industry experts including:
Dr. Mark Powell, Director of MP Scientific
You may be familiar with Dr. Mark Powell as the presenter of our webinar series. This is your opportunity to see Dr. Mark Powell live as he illustrates the use of quality risk management in drug product stability studies. Dr. Mark Powell is a Fellow of the Royal Society of Chemistry (RSC) with over thirty years’ experience as a senior analytical chemist.
Ken O’Shea, Managing Director / Owner of QbD Pharma Solutions and Reso Health
Listen to Ken O’Shea discuss common Qbd principles, how lean principles can be employed to improve pharmaceutical development and the concept of lean stability in regulated environments.
Ken is Managing Director / Owner of QbD Pharma Solutions, which applies Lean & Six Sigma methodologies to all stages of Pharmaceutical Product & Process Development. He is also Co-Founder of Reso Health, an Irish Med Tech company developing a platform to deliver precision nutrition for professionals at work.
Stephen Delaney, Managing Director at Q1 Scientific – a Cambrex company
Finally, gain some practical stability storage tips from Stephen Delaney on inventory management, stability chamber excursions and back-up strategies. As Managing Director of Q1 Scientific – a temperature-controlled stability storage facility, Stephen understands the demands and critical conditions required for pharmaceutical storage.
Who should attend the Stability Studies Conference?
This conference is for:
Stability Programme Managers and Staff
Research & Product Development Scientists and Managers
Analytical Chemists and Microbiologists
QC/QA Professionals
Qualified Persons (EU)
Regulatory Affairs professionals
Where and when is the conference taking place?
Join us at the:
Killashee Hotel, Naas
Thursday 13th October 2022
08:30 – 13:30
How can I register for the Stability Studies Conference?
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
